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doi:10.1016/j.jtcvs.2007.12.065Background: Anomalous origin of the left coronary artery from the pulmonary artery
causes severe myocardial ischemia, global left ventricular dysfunction, and annular
dilatation producing varying degrees of mitral regurgitation. Mitral regurgitation sec-
ondary to the left ventricular or papillary muscle dysfunction in infants will usually
improve in the absence of ongoing ischemia. The aim of this study is to determine
the influence of the degree of preoperative mitral regurgitation on the early and late
outcomes of patients with anomalous origin of the left coronary artery from the pul-
monary artery who underwent coronary reimplantation.
Methods: Twenty-five patients underwent coronary reimplantation and 1 early patient
had ligation during a 30-year period (median age, 4 months; range, 1 month to 16
years), with a median follow-up of 7 years (range, 4 months to 25 years). Before re-
pair, 7 infants (27%) presented in extremis requiring ventilatory and inotropic support,
and 17 patients (65%) presented with heart failure. Mitral regurgitation was present in
all patients: trivial in 6 patients, mild in 12 patients, moderate in 5 patients, and severe
in 3 patients. No patient underwent mitral valve repair or replacement at the time of
anomalous origin of the left coronary artery from the pulmonary artery repair.
Results: Hospital survival was 92%. Three patients underwent mitral valve repair or
replacement at the mean time of 3.5 years (all with severe preoperative mitral regur-
gitation). The degree of mitral regurgitation gradually improved in all remaining pa-
tients with preoperative mild and moderate mitral regurgitation. Echocardiographic
studies demonstrated improvement in left ventricular function in all children. None
of the patients showed any evidence of supravalvar pulmonary stenosis as a result
of their pulmonary artery reconstruction.
Conclusion: Long-term clinical outcome and left ventricular function are good despite
severe left ventricular dysfunction at presentation. Mitral valve repair or replacement
is generally not necessary at the time of anomalous origin of the left coronary artery
from the pulmonary artery repair. Significant residual mitral regurgitation is present in
some patients and can usually be managed surgically at a later date depending on its
degree of severity.
A
nomalous origin of the left coronary artery from the pulmonary artery
(ALCAPA) is a rare congenital anomaly that often insidiously presents
with infarction in early infancy. First described in 1885, the clinical syn-
drome was outlined by Bland and colleagues 1933.1 They demonstrated the combined
effects of the absence of a normal coronary flow with a coronary steal and the pro-
found ischemia that can produce left ventricular (LV) dysfunction and mitral regurgi-
tation (MR).
Several surgical procedures have been described, initially palliative, but more
recently restoring a 2-coronary system, including various forms of bypass graftThe Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 3 743
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DAbbreviations and Acronyms
ALCAPA 5 anomalous origin of the left coronary artery
from the pulmonary artery
ECMO 5 extracorporeal membrane oxygenation
LCA 5 left coronary artery
LV 5 left ventricular
MR 5 mitral regurgitation
MVR 5 mitral valve replacement
PA 5 pulmonary artery
from the aorta,2,3 subclavian artery anastomosis,4 intrapul-
monary bypass graft,5 intrapulmonary artery baffle,6 and di-
rect coronary translocation to the aorta.7–9 What remains
controversial is whether to surgically treat MR at the time
of ALCAPA repair. In ALCAPA, even severe MR has
been reported to fully regress after reimplantation of the
left coronary artery (LCA) into the aorta.3,8
We reviewed our 30-year experience with the surgical
treatment of ALCAPA in infants and children. All patients
but 1 were treated with the establishment of a 2-coronary sys-
tem by directly reimplanting the anomalous LCA into the
aorta and, in general, not treating the mitral valve surgically
at the time of ALCAPA repair.
Materials and Methods
Study Patients
During a 30-year period (from 1975), 26 patients aged 1 month to 16
years (mean, 33.6 6 63.3 months; median, 4 months) underwent
operations at the James Whitcomb Riley Hospital for Children,
Indianapolis, Indiana. Thirteen patients (50%) were female, and
13 patients (50%) were male. Eighteen patients (69%) were aged
less than 6 months at the time of presentation and repair.
Clinical examination, chest roentgenograms, electrocardiogram,
and echocardiography were performed preoperatively in most
patients. At clinical presentation, 7 patients (27%) were critically
ill (requiring mechanical ventilatory and inotropic support), 3 pa-
tients (12%) presented after an episode of ventricular fibrillation,
17 patients (65%) presented with congestive heart failure, 6 patients
(23%) presented with a history of fatigue, 3 patients (12%) presented
with angina, and 2 patients (8%) were asymptomatic but had a mur-
mur. The duration of symptoms before surgical repair ranged from
2 days to 15 months. Electrocardiographic evidence of a transmural
myocardial infarction, defined as the presence of Q waves in leads I
and AVL, was present in 6 patients (23%). Preoperative shortening
fraction was calculated in recent patients by 2-dimensional echocar-
diography using both parasternal long- and short-axis views.
The median preoperative ejection fraction was 20% (mean,
23.1% 6 11.9%; range 10%–54%). Fourteen patients (54%) had
a preoperative ejection fraction less than 20%. The mean preopera-
tive LV end-diastolic diameter was 3.96 0.9 cm. When indexed to
the 95th percentile of normal, the mean preoperative LV end-
diastolic diameter was 1.4 6 0.4 cm (range, 0.8–2.4). Preoperative
mitral valve regurgitation, evaluated by 2-dimensional echocardiog-
raphy and color Doppler flow in most patients, was graded as trivial744 The Journal of Thoracic and Cardiovascular Surgery c Sepin 6 patients, mild in 12 patients, moderate in 5 patients, and severe
in 3 patients. Moderate to severe preoperative mitral valve regurgi-
tation (grade 2 to 41) was detected in 8 patients (31%).
The indication for surgery was the diagnosis of ALCAPA. A
definitive diagnosis was made by echocardiography alone with dem-
onstration of diastolic color Doppler flow from the anomalous cor-
onary artery into the pulmonary artery (PA) in 8 patients (31%). The
echocardiographic suspicion of ALCAPAwas confirmed by cardiac
catheterization in the remaining 18 patients (69%).
Surgical Technique
Operations for all patients were performed via a median sternotomy
with bicaval cannulation and hypothermic cardiopulmonary bypass.
Cardiac arrest was induced by infusion of cold blood potassium
cardioplegic solution through the aortic root, with crossclamping
of both great vessels. The preferred method of handling the anoma-
lous coronary artery was its removal from the transected main PA
and direct reimplantation into the aorta after generous coronary mo-
bilization. The aorta was incised laterally to assist in identifying an
appropriate area above in the left sinus of Valsalva and to avoid
damage or distortion of the aortic valve. This area was generally
slightly higher than the usual origin of the left main coronary artery.
Relocation of the coronary button was accomplished under direct
vision via an adequate opening in the lateral aortic wall to avoid
any damage to the aortic valve leaflets or commissures. Whenever
possible, the coronary button was relocated above the posterior aor-
tic sinus. The posterior defect in the PA was patched with autolo-
gous pericardium in all patients, and the PA was closed. The
mean time of cardioplegic cardiac arrest was 44 6 12 minutes
(range, 19–137 minutes). The mean cardiopulmonary bypass time
was 102 6 28 minutes (range, 40–284 minutes).
In addition to reimplantation of the anomalous LCA into the
aorta, other procedures were performed in 8 patients, including
closure of the atrial septal defect (n5 3), ligation of a patent ductus
arteriosus (n5 2), end-to-end method of coarctation repair (n5 1),
and a partial anomalous pulmonary vein return repair (n5 2). Ster-
nal closure was delayed in 7 patients.
An extracorporeal membrane oxygenation (ECMO) circuit was
used for mechanical circulatory support in 4 patients and interaortic
balloon counterpulsation was used in 1 patient early in our experi-
ence, in whom multiple attempts to wean from cardiopulmonary
bypass failed after prolonged reperfusion. Right and occasionally
left atrial venous and ascending aortic cannulation were used in
all patients.
Statistical Analysis
Data are described as frequencies, medians with ranges, and means
with standard deviations. With missing data, the number of non-
missing values is given. The characteristics and outcomes of patients
in the preoperative period versus those at last follow-up were com-
pared using Fisher exact tests, chi-square tests, t tests, and multivar-
iate logistic regression analysis of variance as appropriate. Estimates
of time-related survival and freedom from reoperation after reim-
plantation were calculated using the Kaplan–Meier method.
Factors associated with postimplantation mortality, need for LV
support, time to extubation from mechanical ventilation, discharge
from the intensive care unit, and development of postoperative ven-
tricular arrhythmias were sought in Cox’s proportionate hazardtember 2008
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censored at the time of death as appropriate. The variables assessed
as possible predictors of these outcomes included age, sex, weight,
body surface area, preoperative symptom severity and duration, ini-
tial presentation with ventricular arrhythmia, preoperative infarction
or ischemia by electrocardiography, preoperative ejection fraction,
LV end-diastolic diameter, severity of MR, presence of associated
diagnoses, date of ALCAPA repair by aortic reimplantation, and
aortic crossclamp time. The need for postoperative ECMO or an aor-
tic balloon pump was also used as a variable assessed as a predictor
of late outcomes.
Differences in survival curves were assessed by log-rank test. All
analyses were performed with the Statistical Package for the Social
Sciences (SPSS Inc, Chicago, Ill). Early mortality was defined as
death during initial hospitalization or within 30 days of operation.
Any deaths later than that were defined as late mortality. In this
series, all early deaths occurred during the initial hospitalization
and all late deaths occurred after discharge from the initial hospital-
ization.
Results
Mortality
There were 2 early deaths and 1 late death, accounting for an
overall mortality of 12%. No mortality has occurred since
1995. The cause of the first early death was sustained ventric-
ular arrhythmias on postoperative day 12; the patient did not
respond to medical therapy and multiple defibrillation
attempts. The second patient underwent ALCAPA repair
with an ejection fraction of 10%. The patient required
ECMO after the procedure and stayed on ECMO for 15
days. On day 8, cerebral hemorrhage was detected and was
progressive on serial head ultrasound examinations. The pa-
tient was weaned from ECMO and was transferred to a com-
munity hospital, where he died 1 month after surgery. This
patient died 29 days after surgery from his neurologic injury.
He had been weaned from ECMO and his cardiac status was
improving.
The late death occurred in a patient who initially under-
went ALCAPA ligation in 1975 as an infant. Preoperatively,
this patient had severe MR, but at the time of ALCAPA liga-
tion the mitral valve was left intact. Three years later, this pa-
tient underwent mitral valve replacement (MVR) with
mechanical prosthesis. The mechanical valve was replaced
twice at 15 and 17 years after the initial MVR. The patient’s
ALCAPA was bypassed with the left internal thoracic artery
16 years after ALCAPA ligation. This patient died 25 years
after the initial ALCAPA ligation because of bacterial endo-
carditis on the prosthetic valve.
Kaplan–Meier survival is 88% 6 6% at 25 years (Fig-
ure 1). Univariate logistic regression identified the time of
surgery (before 1995) as a potential risk factor of mortality
(P 5 .02). Logistic regression demonstrates that severe MR
was not correlated with a higher probability of death. Multi-
variate logistic regression modeling indicates no independent
predictors of death.The Journal of ThoReoperation
Four patients underwent reoperation after ALCAPA repair:
Three patients had severe MR (MVR in 2 patients, and mitral
valve repair in 1 patient), and 1 patient had patch arterioplasty
of a stenotic left main coronary artery. One patient (age, 3
years) underwent MVR (size 25 mm; St Jude Medical, Inc,
Minneapolis, Minn) 2 years after ALCAPA repair. One pa-
tient (age, 5 months) had a DeVega (annuloplasty stitch)
mitral valve annuloplasty 3.5 years after the initial ALCAPA
repair. The third patient (age, 6 months) underwent MVR 3
years after ALCAPA ligation (size 26 mm; Beall-Surgitool,
Medical Engineering Corp, Racine, Wis), but then underwent
repeat MVR twice 9 and 11 years after the initial MVR (size
number 3, Starr-Edwards, Edwards Laboratories, Irvine,
Calif; size 31 mm, St Jude Medical, Inc) and died of mitral
prosthetic endocarditis 25 years after ALCAPA surgery.
The fourth patient with left main coronary artery stenosis un-
derwent left main patch augmentation 9 years after the initial
surgery. No patient underwent a repeat PA repair. Freedom
from reoperation at 25 years was 83%6 9% (Figure 2). Uni-
variate and multivariate logistic regression identified preop-
erative severe MR as a risk factor for reoperation (P, .001).
Figure 1. Kaplan–Meier estimated 25-year survival, including
hospital mortality.
Figure 2. Kaplan–Meier estimated 25-year freedom from
reoperation.racic and Cardiovascular Surgery c Volume 136, Number 3 745
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Follow-up echocardiography (n 5 24) at a mean interval of
10.1 6 8.2 years (median, 7 years; range, 4 months to 25
years) demonstrated a mean ejection fraction of 56.0% 6
13.2% (compared with a mean preoperative ejection fraction
of 23.1% 6 11.9%; P , .0001). MR was trivial in 12 pa-
tients, mild in 10 patients, moderate in 2 patients, and severe
in 1 patient (all 3 patients with moderate or greater MR have
undergone MVR or repair). The degree of MR improved sig-
nificantly during the follow-up period (moderate or severe
MR 31% preoperatively compared with 4% at last follow-
up; P5 .02). Residual wall motion abnormalities were found
in 16 patients and absent in 8 patients, with persistent septal
hypokinesis in 2 patients (8%). Preoperative wall motion
abnormalities were observed in 81% of patients (P 5 .02).
At follow-up in 18 patients, the ratio of the measured LV
end-diastolic diameter to the 95th percentile of normal at
the follow-up period had decreased from 1.6 6 0.3 to 1.0
6 0.3 (range, 0.8–1.4; P , .0001). All patients showed
significant improvement after coronary reimplantation. Color
Doppler echocardiograms in 22 patients indicated that the
reimplanted LCA was widely patent in all patients during
the follow-up period except for the 1 patient who developed
left main stenosis and subsequently had a patch angioplasty.
Normalization of ejection fraction, resolution of LV dila-
tation, improvement in MR, and wall motion abnormalities
usually occurred within 1 year of repair (Figure 3). By mixed
linear regression analysis, the ejection fraction normalized by
5 months, LV dilatation normalized by 6 months, and degree
of MR improved to mild or less by 9 months after the initial
repair except in the 3 patients who eventually required MVR
or repair.
Discussion
ALCAPA is a rare congenital anomaly that often causes myo-
cardial ischemia or infarction within the first few weeks or
months of life, leading to LV dysfunction, mitral valve in-
competence, and congestive heart failure. Several surgical
methods have been developed for treating ALCAPA. Liga-
tion of the LCA at its origin from the PA is rarely performed
today because of high early and late mortality, especially in
small infants.10,11 Establishing a 2-coronary system has
been the main goal of surgical therapy for the last 3 decades.
The continuity of the LCA with the aorta may be established
by several methods. In 1966, Cooley and colleagues2
reported 2 cases of ALCAPA in children in whom an
LCA-aortic anastomosis was created with a Dacron graft in
1 case and an autologous saphenous vein in 1 case. Some sur-
geons recommend anastomosis with the left or right subcla-
vian artery to preclude the necessity of cardioplegic
arrest.12 Anastomosis between the internal thoracic artery
and the LCA has also been proposed as a surgical method
for treating ALCAPA,13 but this procedure is difficult to per-
form in small infants and the late potency of the anastomosis746 The Journal of Thoracic and Cardiovascular Surgery c Sepis uncertain. A 2-coronary system can be created by a Takeu-
chi operation.6 The mortality associated with this procedure
is low, but occurrences of supravalvular pulmonary stenosis,
baffle obstruction, and aortic regurgitation in the late postop-
erative period have been reported.14–16 Direct reimplantation
of the LCA to the aorta is an attractive approach. First re-
ported by Neches and colleagues,7 this procedure has been
successfully used in infants and adults. The operation is cou-
pled with a low mortality and a high rate of anastomotic pa-
tency, and it usually brings about a dramatic improvement in
LV function,15,17 as substantiated by the results of this and
other studies.
The severity of preoperative MR has also been identified
as a risk factor for death after surgery,18 although this is
not supported unanimously.17,19,20 Review of our experience
did not identify severe MR as a risk factor for mortality. Both
early deaths in this series occurred in infants with mild to
moderate regurgitation. On the basis of our experience, we
have developed a general policy not to address MR by repair
or replacement at the initial operation. In ALCAPA, even se-
vere MR has been reported to fully regress after reperfusion
alone in the majority of cases.21,22 In the present study, mitral
valve regurgitation had already improved significantly by the
time of hospital discharge when compared with the preoper-
ative findings. Furthermore, freedom from MR greater than
mild at 25 years was 88% in all but the 3 patients who had
Figure 3. Longitudinal changes in the degree of MR with the cor-
responding number of patients at risk.MVR,Mitral valve replace-
ment; MR, mitral regurgitation.tember 2008
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Dundergone MVR or repair. Thus, the primary goal of the ini-
tial surgery should be to establish antegrade coronary perfu-
sion.
Some authors23 recommend routine mitral valve repair at
the time of coronary artery revascularization on the grounds
that early postoperative cardiac output is improved and oper-
ative mortality is reduced. It remains speculative whether
their excellent results would have been achieved without as-
sociated mitral valve procedures or if their patients were
mostly infants, as in our study. Others advocate mitral annu-
loplasty15,20,24 or MVR14,24 only in the presence of severe
MR. In our mostly infant patient population, the mitral valve
was not addressed at the initial repair. When we analyzed our
results and adverse outcomes, our philosophy of not repairing
moderate or severe MR at the initial ALCAPA repair sup-
ports our approach. All 3 patients with severe preoperative
MR also had severe LV dysfunction. All 3 infants survived
ALCAPA repairs and in our opinion would have been better
candidates for a definitive mitral valve repair (n 5 1) or re-
placement (n5 2) if they had been older, they had recovered
from the myocardial ischemia caused by ALCAPA, and their
left ventricles had improved or returned to normal function.
The 2 early deaths in the 5 patients who presented with mod-
erate MR were infants (,4 months old) with severe LV dys-
function (EF , 20%). One patient died of an arrhythmia 12
days after coronary reimplantation when LV function was be-
ginning to improve. The other infant died of a cerebral bleed
as he was being weaned successfully from ECMO. He died 3
weeks later of neurologic complications, but his cardiac func-
tion had already improved significantly. We doubt that mitral
valve repair would have changed these patients’ outcomes.
We would agree with Isomatsu and coauthors23 that mitral
valve repair can and should be considered in an older child
if the regurgitation is moderately severe or severe and they
cannot be weaned from mechanical support.
MVR or repair during ALCAPA repair would prolong the
ischemic insult to the sick infant ventricle and is potentially
harmful by acutely increasing the afterload in an already
damaged ventricle. Severe MR was a risk factor for reopera-
tion but not a risk factor for death in this series.
Occlusion or stenosis of the LCA after reimplantation of
the ALCAPA is rarely seen. Stenosis or occlusion is usually
related to the excessive tension placed on this vessel to reach
the aorta and from its distant position on the posterolateral as-
pect of the main PA. Disruption of the vasa vasorummay also
play a role. When late obstruction of the left coronary occurs
after the reimplantation, revascularization of the LCA can be
accomplished by patch angioplasty of the left main coronary
artery25 or coronary bypass using an internal thoracic artery.
Coronary bypass with the left internal thoracic artery can be
successfully performed even in very young children.26
Encouraging results have been achieved with the use of
cardiac mechanical support as a bridge to recovery in the
postoperative setting of ALCAPA.15,21,25,27,28 Such supportThe Journal of Thormeasures include LV assist devices,21,27 ECMO,15,25,29 and
intra-aortic balloon pumps30 in older children. In a report
by Del Nido and associates,27 5 survivors among 7 infants
who underwent surgical correction of ALCAPA and intracta-
ble LV failure were successfully supported with an LV assist
device. In our series of patients with ALCAPA, we have not
used LV assist devices, but 5 infants required short-term post-
operative mechanical support after direct aortic reimplanta-
tion and 4 infants were long-term survivors. Mechanical
assistance improves results and maximally enhances patient
survival; LV assist devices and ECMO play an obvious inte-
gral part in the modern surgical treatment of patients with
ALCAPA.
Conclusions
ALCAPA repair by establishing a 2-coronary myocardial
perfusion offers the best potential for LV functional recovery.
Coronary reimplantation offers superior long-term survival
and a higher freedom from reoperation than alternative tech-
niques. MVR or repair is generally not necessary at the time
of the initial operation and is potentially harmful by acutely
increasing LV afterload in these sick ventricles. All 3 patients
in this series who presented with severe MR tolerated a 21-
year delay for their subsequent MVR or repair. Moderate MR
will generally improve in the majority of patients after AL-
CAPA repair, andMV regurgitation should only be corrected
in the rare patient who cannot be weaned from bypass or post-
operative mechanical support.
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